Table 5.
Gene | Protein/RNP function | Target Genes | Biological consequences | Type of cancer | Expression in cancer | Ref |
---|---|---|---|---|---|---|
XPO1/CRM1 | Exportin 1, ubiquitous nuclear export | protein export p53, NPM1, NFκB | anti-apoptotic properties | AML, ALL, CML, CLL, lymphoma, MM | upregulation | reviewed in67 |
eIF4E | cap-dependent mRNA nuclear export and translation | CCND1 | delays granulocytic and monocytic differentiation, promotes leukemogenesis | AML, BC CML, ALL | upregulation | 70 |
MYC, BCL2, BCL6, B-cell receptor signaling, metabolism, and epigenetic regulation | promotes proliferation, aggressiveness | aggressive double- and triple-hit (DH/TH) DLBCL with active Hsp90 stress pathway | 71 |
Abbreviations used: Acute myeloid leukemia (AML); acute promyeloblastic leukemia (APL); acute megakaryoblastic leukemia (AMKL); acute lymphoblastic or lymphocytic (ALL); B-cell acute lymphoblastic leukemia (B-ALL); adult T-cell leukemia/lymphoma (ATL); diffuse large B-cell lymphomas (DLBCLs); chronic myeloid leukemia (CML), chronic phase (CP), accelerated phase (AP), blast crisis (BC); chronic lymphoblastic or lymphocytic leukemia (CLL); myelodysplastic syndromes (MDS); multiple myeloma (MM); hepatocellular carcinoma (HCC); leukemia stem cell (LSC); wild type (WT); patient-derived xenograft (PDX); bone marrow (BM); hematopoietic stem/progenitor cells (HSCs, HSPCs).